Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002392064 | SCV002702790 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-07-10 | criteria provided, single submitter | clinical testing | The p.L477S variant (also known as c.1430T>C), located in coding exon 9 of the BRIP1 gene, results from a T to C substitution at nucleotide position 1430. The leucine at codon 477 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003464515 | SCV004214702 | uncertain significance | Familial cancer of breast | 2023-10-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492761 | SCV004240385 | uncertain significance | Breast and/or ovarian cancer | 2022-12-19 | criteria provided, single submitter | clinical testing |